Year: 2013
Type: article
Study design: Observational Study
Abstract: Engraftment syndrome (ES), characterized by noninfectious fever, rash, diarrhea, and/or respiratory symptoms during engraftment, can be associated with increased morbidity and resource utilization (e.g., IV antibiotics, hospitalization) after autologous stem cell transplant (ASCT). ES remains a clinical diagnosis, without confirmed biomarkers or standardized treatment recommendations. Herein, we describe the clinical, laboratory, and outcomes data from a large contemporary cohort of ASCT recipients and suggest new diagnostic criteria.
Authors: Brian Leslie Burnette, Morie Gertz, Shaji Kumar, Martha Lacy, Francis Buadi, Suzanne Hayman, David Dingli, David J. Inwards, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, William Hogan, Mark R. Litzow, Mrinal Patnaik, Shahrukh Hashmi, Nelson Leung, Bekele Afessa, Dennis Gastineau, Stephen M. Ansell, Shernan Holtan, Angela Dispenzieri
Institutions: Mayo Clinic, Oregon Health & Science University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2109612036